Global Interventional Cardiology Market - 2024-2031
Market Size
The Global Interventional Cardiology Market reached US$ 14.47 billion in 2023 and is expected to reach US$ 28.67 billion by 2031, growing at a CAGR of 9.1% during the forecast period 2024-2031.
Interventional cardiology is a medical specialty that uses a thin, flexible tube known as a catheter to repair damaged or weakened vessels, narrowed arteries, or other structural issues with the heart. Cardiac interventions frequently eliminate the need for open-heart surgery and provide better outcomes than medication therapy.
It is an important advancement in cardiovascular care, providing patients with effective treatment alternatives that involve fewer risks and faster recovery times. As technology advances, this field is anticipated to develop further, embracing novel treatments and equipment that improve patient outcomes when managing heart disease. Interventional cardiology treats acute and chronic cardiovascular conditions by threading thin catheters and specialized tools to clear the blockage and restore blood flow. It uses minimally invasive procedures to diagnose and treat heart diseases
As per the American Medical Association, interventional cardiology is a branch of medicine within cardiology that evaluates blood flow, and pressure in the coronary arteries and chambers of the heart with the help of specialized imaging and other diagnostic techniques also involves the technical procedures and medications utilized for those abnormalities impairing the functions of the cardiovascular system.
Market Dynamics
The growing cases of cardiovascular diseases, geriatric populations, lifestyle changes, and increasing awareness about cardiovascular diseases are fueling the global interventional cardiology market growth.
The new product launches boost the global interventional cardiology market during the forecast period.
Increasing launches of innovative products is expected to be one
of the significant growth factors for the interventional cardiology
market.
Increased new product launches are considerably driving the interventional cardiology market by expanding treatment options, increasing patient outcomes, and addressing the rising prevalence of cardiovascular diseases. For instance, Abbott launched XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India.
XIENCE Sierra is one of the latest generation stents in the XIENCE family, now available to people suffering from blocked coronary arteries. For interventional cardiologists, it brings unparalleled safety to the most complex cases.
In 2024, BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions (PCI).
The stringent regulations and high costs hinder the global interventional cardiology market growth.
However, the high cost of cardiological intervention and stringent regulations will hamper the global interventional cardiology market during the forecast period. For instance, the U.S. FDA is revising two guidance documents for vendors inventing new coronary, peripheral, and neurovascular guidewires. The FDA reported the draft documents in June 2018 and is yet to gather comments on one of the documents. These documents are expected to cover the performance testing, recommended labeling, and lubricious coatings, which will provide industry and FDA staff with suggestions on the least tyrannical means of evaluating the performance of catheters, guidewires, and delivery systems submitted in premarket approval applications (PMAs) or 510(k) premarket notifications. Furthermore, the average cost of percutaneous coronary intervention for chronic total occlusions was $14,946 ± 7,699, leaving a majority of the population unable to get it performed, thus slowing the global interventional cardiology market growth during the forecast period.
COVID-19 Impact Analysis
The COVID-19 pandemic hurt the global interventional cardiology market since, during the pandemic, there was a large downfall in interventional cardiology procedures. For instance, the British Cardiovascular Interventional society performed a retrospective analysis of all percutaneous coronary interventions (PCI) performed in the United Kingdom during the lockdown imposed by the pandemic in comparison with PCI volumes in the pre-pandemic period.
The retrospective analysis concluded that there was 49% less PCI, with stable angina being hit the hardest, showing a 66% reduction, while the PCI for ST-elevation MI (STEMI) was down by 33%. Furthermore, the pandemic changed people's perspective toward healthy lifestyle choices, which caused a reduction in the cases of cardiovascular diseases, therefore impacting global interventional cardiology negatively.
Market Segmentation Analysis
The stents are predicted to have a high demand during the forecast period (2024-2031).
The stents are expected to dominate the global interventional cardiology market during the forecast period (2024-2031), owing to the new introductions and product approvals in the global interventional cardiology market. For instance, in August 2021, SINOMED launched its HT Supreme Drug-Eluting Stent (DES) in Europe through the first commercial implantation at University Hospital Galway in partnership with the National University of Ireland Galway (NUI Galway). Likewise, in May 2022, the United States Food and Drug Administration (FDA) approved Medtronic plc's Onyx Frontier drug-eluting stent (DES). Onyx Frontier DES leverages the same stent platform as Resolute Onyx DES and with an enhanced delivery system.
Similarly, in January 2021, the FDA approved the Synergy Megatron Drug Eluting stent from Boston Scientific, designed to treat large proximal near the aorta. Furthermore, in May 2021, the CE mark was received by a novel polymer-free self-expanding Amphilimus eluting stent, NiTiDES, from form Alvimedica for superficial femoral artery (SFA) lesions. Therefore, from the above data, stents are anticipated to dominate the global interventional cardiology market throughout the forecast period.
Market Geographical Share
North America is predicted to command the global interventional cardiology market.
North America is estimated to hold a large market over the forecast period (2023-2031) owing to the rising cases of cardiovascular diseases and the presence of key market players in this region. According to the CDC, a U.S. American dies every 34 seconds because of cardiovascular disease. In 2020, cardiovascular disease caused over 697,000 deaths. Furthermore, the existence of key market players such as Abbott, Edwards Lifesciences Corporation, Boston Scientific Corporation, Johnson & Johnson, Medtronic, and Cook Medical Inc., holding large shares of the global interventional cardiology market through different market strategies, are based in the United States, ensures the dominance of this region over the global interventional cardiology market. For instance, in September 2021, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots.
Similarly, in August 2022, GE Healthcare collaborated with Boston Scientific to provide innovative interventional cardiac care solutions in India. Furthermore, in January 2022, Medtronic acquired Affero expanding Medtronic's cardiac ablation portfolio. Also, in November 2021, Medtronic launched Arctic Front Advanced Cardiac Cryoablation Catheter Technology for treating Atrial Fibrillation in India. Thus, the data shows North America will dominate the global interventional cardiology market throughout the forecast period.
Market Competitive Landscape
The major global interventional cardiology market players are Abbott, Boston Scientific Corporation, Johnson & Johnson, Medtronic, B.Barun Melsungen, Biosensors International Ltd., Terumo Corporation, Biotronik SE and Co. KG, Edwards Lifesciences Corporation and Cook Medical Inc. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the interventional cardiology market globally. For instance, in July 2022, Terumo India signed a new strategic commercial distribution partnership with Sensible Medical Innovations.
Medtronic, Plc.
Overview:
Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.
Product Portfolio:
The product portfolio of Medtronic, Plc. for interventional cardiology contains Endurant II Stent Graft Systems: Which provides the ideal of care with a history of clinical success in treating abdominal aortic aneurysms (AAA). Only the Endurant family of products was developed to address sac regression.
The Global Interventional Cardiology Market reached US$ 14.47 billion in 2023 and is expected to reach US$ 28.67 billion by 2031, growing at a CAGR of 9.1% during the forecast period 2024-2031.
Interventional cardiology is a medical specialty that uses a thin, flexible tube known as a catheter to repair damaged or weakened vessels, narrowed arteries, or other structural issues with the heart. Cardiac interventions frequently eliminate the need for open-heart surgery and provide better outcomes than medication therapy.
It is an important advancement in cardiovascular care, providing patients with effective treatment alternatives that involve fewer risks and faster recovery times. As technology advances, this field is anticipated to develop further, embracing novel treatments and equipment that improve patient outcomes when managing heart disease. Interventional cardiology treats acute and chronic cardiovascular conditions by threading thin catheters and specialized tools to clear the blockage and restore blood flow. It uses minimally invasive procedures to diagnose and treat heart diseases
As per the American Medical Association, interventional cardiology is a branch of medicine within cardiology that evaluates blood flow, and pressure in the coronary arteries and chambers of the heart with the help of specialized imaging and other diagnostic techniques also involves the technical procedures and medications utilized for those abnormalities impairing the functions of the cardiovascular system.
Market Dynamics
The growing cases of cardiovascular diseases, geriatric populations, lifestyle changes, and increasing awareness about cardiovascular diseases are fueling the global interventional cardiology market growth.
The new product launches boost the global interventional cardiology market during the forecast period.
Increasing launches of innovative products is expected to be one
of the significant growth factors for the interventional cardiology
market.
Increased new product launches are considerably driving the interventional cardiology market by expanding treatment options, increasing patient outcomes, and addressing the rising prevalence of cardiovascular diseases. For instance, Abbott launched XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India.
XIENCE Sierra is one of the latest generation stents in the XIENCE family, now available to people suffering from blocked coronary arteries. For interventional cardiologists, it brings unparalleled safety to the most complex cases.
In 2024, BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions (PCI).
The stringent regulations and high costs hinder the global interventional cardiology market growth.
However, the high cost of cardiological intervention and stringent regulations will hamper the global interventional cardiology market during the forecast period. For instance, the U.S. FDA is revising two guidance documents for vendors inventing new coronary, peripheral, and neurovascular guidewires. The FDA reported the draft documents in June 2018 and is yet to gather comments on one of the documents. These documents are expected to cover the performance testing, recommended labeling, and lubricious coatings, which will provide industry and FDA staff with suggestions on the least tyrannical means of evaluating the performance of catheters, guidewires, and delivery systems submitted in premarket approval applications (PMAs) or 510(k) premarket notifications. Furthermore, the average cost of percutaneous coronary intervention for chronic total occlusions was $14,946 ± 7,699, leaving a majority of the population unable to get it performed, thus slowing the global interventional cardiology market growth during the forecast period.
COVID-19 Impact Analysis
The COVID-19 pandemic hurt the global interventional cardiology market since, during the pandemic, there was a large downfall in interventional cardiology procedures. For instance, the British Cardiovascular Interventional society performed a retrospective analysis of all percutaneous coronary interventions (PCI) performed in the United Kingdom during the lockdown imposed by the pandemic in comparison with PCI volumes in the pre-pandemic period.
The retrospective analysis concluded that there was 49% less PCI, with stable angina being hit the hardest, showing a 66% reduction, while the PCI for ST-elevation MI (STEMI) was down by 33%. Furthermore, the pandemic changed people's perspective toward healthy lifestyle choices, which caused a reduction in the cases of cardiovascular diseases, therefore impacting global interventional cardiology negatively.
Market Segmentation Analysis
The stents are predicted to have a high demand during the forecast period (2024-2031).
The stents are expected to dominate the global interventional cardiology market during the forecast period (2024-2031), owing to the new introductions and product approvals in the global interventional cardiology market. For instance, in August 2021, SINOMED launched its HT Supreme Drug-Eluting Stent (DES) in Europe through the first commercial implantation at University Hospital Galway in partnership with the National University of Ireland Galway (NUI Galway). Likewise, in May 2022, the United States Food and Drug Administration (FDA) approved Medtronic plc's Onyx Frontier drug-eluting stent (DES). Onyx Frontier DES leverages the same stent platform as Resolute Onyx DES and with an enhanced delivery system.
Similarly, in January 2021, the FDA approved the Synergy Megatron Drug Eluting stent from Boston Scientific, designed to treat large proximal near the aorta. Furthermore, in May 2021, the CE mark was received by a novel polymer-free self-expanding Amphilimus eluting stent, NiTiDES, from form Alvimedica for superficial femoral artery (SFA) lesions. Therefore, from the above data, stents are anticipated to dominate the global interventional cardiology market throughout the forecast period.
Market Geographical Share
North America is predicted to command the global interventional cardiology market.
North America is estimated to hold a large market over the forecast period (2023-2031) owing to the rising cases of cardiovascular diseases and the presence of key market players in this region. According to the CDC, a U.S. American dies every 34 seconds because of cardiovascular disease. In 2020, cardiovascular disease caused over 697,000 deaths. Furthermore, the existence of key market players such as Abbott, Edwards Lifesciences Corporation, Boston Scientific Corporation, Johnson & Johnson, Medtronic, and Cook Medical Inc., holding large shares of the global interventional cardiology market through different market strategies, are based in the United States, ensures the dominance of this region over the global interventional cardiology market. For instance, in September 2021, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots.
Similarly, in August 2022, GE Healthcare collaborated with Boston Scientific to provide innovative interventional cardiac care solutions in India. Furthermore, in January 2022, Medtronic acquired Affero expanding Medtronic's cardiac ablation portfolio. Also, in November 2021, Medtronic launched Arctic Front Advanced Cardiac Cryoablation Catheter Technology for treating Atrial Fibrillation in India. Thus, the data shows North America will dominate the global interventional cardiology market throughout the forecast period.
Market Competitive Landscape
The major global interventional cardiology market players are Abbott, Boston Scientific Corporation, Johnson & Johnson, Medtronic, B.Barun Melsungen, Biosensors International Ltd., Terumo Corporation, Biotronik SE and Co. KG, Edwards Lifesciences Corporation and Cook Medical Inc. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the interventional cardiology market globally. For instance, in July 2022, Terumo India signed a new strategic commercial distribution partnership with Sensible Medical Innovations.
Medtronic, Plc.
Overview:
Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.
Product Portfolio:
The product portfolio of Medtronic, Plc. for interventional cardiology contains Endurant II Stent Graft Systems: Which provides the ideal of care with a history of clinical success in treating abdominal aortic aneurysms (AAA). Only the Endurant family of products was developed to address sac regression.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The Growing Prevalence of Cardio-vascular diseases
4.1.1.2. Growing Geriatric Population
4.1.2. Restraints
4.1.2.1. High Cost of Cardiological Intervention Procedures
4.1.2.2. Stringent Regulation
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Stents
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.2.2.1. Bare-Metal
7.2.2.2. Drug-eluting
7.2.2.3. Bio-absorbable
7.3. Catheters
7.3.1. Angioplasty
7.3.2. Guiding
7.3.3. Pulmonary Artery
7.3.4. Intravascular Ultrasound (IVUS)
7.4. PTCA balloons
7.4.1. Normal
7.4.2. Cutting
7.4.3. Scoring
7.4.4. Drug-eluting
7.5. Image Systems
7.5.1. IVUS (intravascular Ultrasound)
7.5.2. FFR (Fractional Flow Service)
7.5.3. OCT (Optical coherence Tomography)
7.6. Laser Procedures
7.7. Atherectomy
7.8. Others (Guidewires)
8. BY END USER
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
8.1.2. Market Attractiveness Index, By End User Segment
8.2. Hospitals
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Others
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. The U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. The U.K.
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10. COMPETITIVE LANDSCAPE
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking
11. COMPANY PROFILES
11.1. Medtronic Plc
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Abbott
11.3. Boston Scientific Corporation
11.4. Johnson & Johnson
11.5. B.Barun Melsungen
11.6. Biosensors International Ltd.
11.7. Terumo Corporation
11.8. Biotronik SE and Co KG
11.9. Edwards Lifesciences Corporation
11.10. Cook Medical Inc.(*LIST NOT EXHAUSTIVE)
12. DATAM INTELLIGENCE
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The Growing Prevalence of Cardio-vascular diseases
4.1.1.2. Growing Geriatric Population
4.1.2. Restraints
4.1.2.1. High Cost of Cardiological Intervention Procedures
4.1.2.2. Stringent Regulation
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Stents
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.2.2.1. Bare-Metal
7.2.2.2. Drug-eluting
7.2.2.3. Bio-absorbable
7.3. Catheters
7.3.1. Angioplasty
7.3.2. Guiding
7.3.3. Pulmonary Artery
7.3.4. Intravascular Ultrasound (IVUS)
7.4. PTCA balloons
7.4.1. Normal
7.4.2. Cutting
7.4.3. Scoring
7.4.4. Drug-eluting
7.5. Image Systems
7.5.1. IVUS (intravascular Ultrasound)
7.5.2. FFR (Fractional Flow Service)
7.5.3. OCT (Optical coherence Tomography)
7.6. Laser Procedures
7.7. Atherectomy
7.8. Others (Guidewires)
8. BY END USER
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
8.1.2. Market Attractiveness Index, By End User Segment
8.2. Hospitals
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Others
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. The U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. The U.K.
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10. COMPETITIVE LANDSCAPE
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking
11. COMPANY PROFILES
11.1. Medtronic Plc
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Abbott
11.3. Boston Scientific Corporation
11.4. Johnson & Johnson
11.5. B.Barun Melsungen
11.6. Biosensors International Ltd.
11.7. Terumo Corporation
11.8. Biotronik SE and Co KG
11.9. Edwards Lifesciences Corporation
11.10. Cook Medical Inc.(*LIST NOT EXHAUSTIVE)
12. DATAM INTELLIGENCE
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us
LIST OF TABLES
Table No 1 Global Interventional Cardiology Market Value, By Type, 2023, 2027 & 2031 ($ Million)
Table No 2 Global Interventional Cardiology Market Value, By End User, 2023, 2027 & 2031 ($ Million)
Table No 3 Global Interventional Cardiology Market Value, By Region, 2023, 2027 & 2031 ($ Million)
Table No 4 Global Interventional Cardiology Market Value, By Type, 2023, 2027 & 2031 ($ Million)
Table No 5 Global Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 6 Global Interventional Cardiology Market Value, By End User, 2023, 2027 & 2031 ($ Million)
Table No 7 Global Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 8 Global Interventional Cardiology Market Value, By Region, 2023, 2027 & 2031 ($ Million)
Table No 9 Global Interventional Cardiology Market Value, By Region, 2022-2031 ($ Million)
Table No 10 North America Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 11 North America Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 12 North America Interventional Cardiology Market Value, By Country, 2022-2031 ($ Million)
Table No 13 South America Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 14 South America Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 15 South America Interventional Cardiology Market Value, By Country, 2022-2031 ($ Million)
Table No 16 Europe Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 17 Europe Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 18 Europe Interventional Cardiology Market Value, By Country, 2022-2031 ($ Million)
Table No 19 Asia-Pacific Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 20 Asia-Pacific Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 21 Asia-Pacific Interventional Cardiology Market Value, By Country, 2022-2031 ($ Million)
Table No 22 Middle East & Africa Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 23 Middle East & Africa Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 24 Medtronic Plc: Overview
Table No 25 Medtronic Plc: Product Portfolio
Table No 26 Medtronic Plc: Key Developments
Table No 27 Abbott: Overview
Table No 28 Abbott: Product Portfolio
Table No 29 Abbott: Key Developments
Table No 30 Boston Scientific Corporation: Overview
Table No 31 Boston Scientific Corporation: Product Portfolio
Table No 32 Boston Scientific Corporation: Key Developments
Table No 33 Johnson & Johnson: Overview
Table No 34 Johnson & Johnson: Product Portfolio
Table No 35 Johnson & Johnson: Key Developments
Table No 36 B.Barun Melsungen: Overview
Table No 37 B.Barun Melsungen: Product Portfolio
Table No 38 B.Barun Melsungen: Key Developments
Table No 39 Biosensors International Ltd.: Overview
Table No 40 Biosensors International Ltd.: Product Portfolio
Table No 41 Biosensors International Ltd.: Key Developments
Table No 42 Terumo Corporation: Overview
Table No 43 Terumo Corporation: Product Portfolio
Table No 44 Terumo Corporation: Key Developments
Table No 45 Biotronik SE and Co KG: Overview
Table No 46 Biotronik SE and Co KG: Product Portfolio
Table No 47 Biotronik SE and Co KG: Key Developments
Table No 48 Edwards Lifesciences Corporation: Overview
Table No 49 Edwards Lifesciences Corporation: Product Portfolio
Table No 50 Edwards Lifesciences Corporation: Key Developments
Table No 51 Cook Medical Inc.: Overview
Table No 52 Cook Medical Inc.: Product Portfolio
Table No 53 Cook Medical Inc.: Key Developments
Table No 1 Global Interventional Cardiology Market Value, By Type, 2023, 2027 & 2031 ($ Million)
Table No 2 Global Interventional Cardiology Market Value, By End User, 2023, 2027 & 2031 ($ Million)
Table No 3 Global Interventional Cardiology Market Value, By Region, 2023, 2027 & 2031 ($ Million)
Table No 4 Global Interventional Cardiology Market Value, By Type, 2023, 2027 & 2031 ($ Million)
Table No 5 Global Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 6 Global Interventional Cardiology Market Value, By End User, 2023, 2027 & 2031 ($ Million)
Table No 7 Global Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 8 Global Interventional Cardiology Market Value, By Region, 2023, 2027 & 2031 ($ Million)
Table No 9 Global Interventional Cardiology Market Value, By Region, 2022-2031 ($ Million)
Table No 10 North America Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 11 North America Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 12 North America Interventional Cardiology Market Value, By Country, 2022-2031 ($ Million)
Table No 13 South America Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 14 South America Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 15 South America Interventional Cardiology Market Value, By Country, 2022-2031 ($ Million)
Table No 16 Europe Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 17 Europe Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 18 Europe Interventional Cardiology Market Value, By Country, 2022-2031 ($ Million)
Table No 19 Asia-Pacific Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 20 Asia-Pacific Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 21 Asia-Pacific Interventional Cardiology Market Value, By Country, 2022-2031 ($ Million)
Table No 22 Middle East & Africa Interventional Cardiology Market Value, By Type, 2022-2031 ($ Million)
Table No 23 Middle East & Africa Interventional Cardiology Market Value, By End User, 2022-2031 ($ Million)
Table No 24 Medtronic Plc: Overview
Table No 25 Medtronic Plc: Product Portfolio
Table No 26 Medtronic Plc: Key Developments
Table No 27 Abbott: Overview
Table No 28 Abbott: Product Portfolio
Table No 29 Abbott: Key Developments
Table No 30 Boston Scientific Corporation: Overview
Table No 31 Boston Scientific Corporation: Product Portfolio
Table No 32 Boston Scientific Corporation: Key Developments
Table No 33 Johnson & Johnson: Overview
Table No 34 Johnson & Johnson: Product Portfolio
Table No 35 Johnson & Johnson: Key Developments
Table No 36 B.Barun Melsungen: Overview
Table No 37 B.Barun Melsungen: Product Portfolio
Table No 38 B.Barun Melsungen: Key Developments
Table No 39 Biosensors International Ltd.: Overview
Table No 40 Biosensors International Ltd.: Product Portfolio
Table No 41 Biosensors International Ltd.: Key Developments
Table No 42 Terumo Corporation: Overview
Table No 43 Terumo Corporation: Product Portfolio
Table No 44 Terumo Corporation: Key Developments
Table No 45 Biotronik SE and Co KG: Overview
Table No 46 Biotronik SE and Co KG: Product Portfolio
Table No 47 Biotronik SE and Co KG: Key Developments
Table No 48 Edwards Lifesciences Corporation: Overview
Table No 49 Edwards Lifesciences Corporation: Product Portfolio
Table No 50 Edwards Lifesciences Corporation: Key Developments
Table No 51 Cook Medical Inc.: Overview
Table No 52 Cook Medical Inc.: Product Portfolio
Table No 53 Cook Medical Inc.: Key Developments
LIST OF FIGURES
Figure No 1 Global Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 2 Global Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 3 Global Interventional Cardiology Market Share, By Region, 2022 & 2031 (%)
Figure No 4 Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 5 Global Interventional Cardiology Market Y-o-Y Growth, By Type, 2022-2031 (%)
Figure No 6 Stents: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 7 Catheters: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 8 PTCA balloons: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 9 Image Systems: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 10 Laser Procedures: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 11 Atherectomy: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 12 Others (Guidewires): Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 13 Global Interventional Cardiology Market Y-o-Y Growth, By End User, 2022-2031 (%)
Figure No 14 Hospitals: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 15 Ambulatory Surgical Centers (ASCs): Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 16 Others: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 17 Global Interventional Cardiology Market Y-o-Y Growth, By Region, 2022-2031 (%)
Figure No 18 North America Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 19 North America Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 20 North America Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 21 North America Interventional Cardiology Market Share, By Country, 2022 & 2031 (%)
Figure No 22 South America Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 23 South America Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 24 South America Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 25 South America Interventional Cardiology Market Share, By Country, 2022 & 2031 (%)
Figure No 26 Europe Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 27 Europe Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 28 Europe Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 29 Europe Interventional Cardiology Market Share, By Country, 2022 & 2031 (%)
Figure No 30 Asia-Pacific Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 31 Asia-Pacific Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 32 Asia-Pacific Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 33 Asia-Pacific Interventional Cardiology Market Share, By Country, 2022 & 2031 (%)
Figure No 34 Middle East & Africa Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 35 Middle East & Africa Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 36 Middle East & Africa Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 37 Medtronic Plc: Financials
Figure No 38 Abbott: Financials
Figure No 39 Boston Scientific Corporation: Financials
Figure No 40 Johnson & Johnson: Financials
Figure No 41 B.Barun Melsungen: Financials
Figure No 42 Biosensors International Ltd.: Financials
Figure No 43 Terumo Corporation: Financials
Figure No 44 Biotronik SE and Co KG: Financials
Figure No 45 Edwards Lifesciences Corporation: Financials
Figure No 46 Cook Medical Inc.: Financials
Figure No 1 Global Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 2 Global Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 3 Global Interventional Cardiology Market Share, By Region, 2022 & 2031 (%)
Figure No 4 Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 5 Global Interventional Cardiology Market Y-o-Y Growth, By Type, 2022-2031 (%)
Figure No 6 Stents: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 7 Catheters: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 8 PTCA balloons: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 9 Image Systems: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 10 Laser Procedures: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 11 Atherectomy: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 12 Others (Guidewires): Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 13 Global Interventional Cardiology Market Y-o-Y Growth, By End User, 2022-2031 (%)
Figure No 14 Hospitals: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 15 Ambulatory Surgical Centers (ASCs): Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 16 Others: Global Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 17 Global Interventional Cardiology Market Y-o-Y Growth, By Region, 2022-2031 (%)
Figure No 18 North America Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 19 North America Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 20 North America Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 21 North America Interventional Cardiology Market Share, By Country, 2022 & 2031 (%)
Figure No 22 South America Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 23 South America Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 24 South America Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 25 South America Interventional Cardiology Market Share, By Country, 2022 & 2031 (%)
Figure No 26 Europe Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 27 Europe Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 28 Europe Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 29 Europe Interventional Cardiology Market Share, By Country, 2022 & 2031 (%)
Figure No 30 Asia-Pacific Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 31 Asia-Pacific Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 32 Asia-Pacific Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 33 Asia-Pacific Interventional Cardiology Market Share, By Country, 2022 & 2031 (%)
Figure No 34 Middle East & Africa Interventional Cardiology Market Value, 2022-2031 ($ Million)
Figure No 35 Middle East & Africa Interventional Cardiology Market Share, By Type, 2022 & 2031 (%)
Figure No 36 Middle East & Africa Interventional Cardiology Market Share, By End User, 2022 & 2031 (%)
Figure No 37 Medtronic Plc: Financials
Figure No 38 Abbott: Financials
Figure No 39 Boston Scientific Corporation: Financials
Figure No 40 Johnson & Johnson: Financials
Figure No 41 B.Barun Melsungen: Financials
Figure No 42 Biosensors International Ltd.: Financials
Figure No 43 Terumo Corporation: Financials
Figure No 44 Biotronik SE and Co KG: Financials
Figure No 45 Edwards Lifesciences Corporation: Financials
Figure No 46 Cook Medical Inc.: Financials
